The purpose of SPERCO is to produce effective and safe pharmaceutical products, using the latest global advancements in the industry as a foundation for generating profit. Among SPERCO’s strategic plans are expanding its product portfolio (currently, more than 20 new products are in development), strengthening its position in both the Ukrainian and international markets, as well as focus on innovations to increase product effectiveness indicators. SPERCO plans to significantly increase company’s production volumes during the next 5 years, placing itself among the TOP-10 Ukrainian pharmaceutical manufacturers.


The independent analytical company Proxima Research estimated SPERCO’s retail sales in 2023 at 1.02 billion hryvnias and more than 6 million packs sold in Ukraine. The TOP-3 products with the highest sales in hryvnia equivalent in 2023, were Noxprey, Tos-Mai and Kremgen. The company demonstrated faster growth than the Ukrainian market as a whole, being amidst the TOP-30 largest pharmaceutical companies of Ukraine from among more than 370 active local and international companies.


SPERCO is an efficient team of like-minded people each of which being an expert in the area of his activity in the pharmaceutical business. Employees have long-term professional experience to improve current products and search for innovative and far-reaching decisions for the development of the pharmaceutical market in Ukraine and abroad. Our company is open to opportunities for cooperation in registration, import, production, marketing and promotion of pharmaceutical products. We will be glad to start mutually beneficial collaboration with Your company!

For cooperation in Ukraine:

Volodymyr Rovda

Tel.: +38 (067) 443 11 56



For cooperation in other countries:

Nataliia Iskorkina

Tel.: +38 (067) 434 19 44